Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALS Untangled does not support using Mototab for motor neuron disease

Original source

MototabALSUntangled · 3 January 2012 (opens in a new tab)

ALS Untangled said it does not support using Mototab for amyotrophic lateral sclerosis (ALS) or any other motor neuron disease. The group cited a lack of demonstrated effectiveness and concerns about the product’s safety and supplier identity and reliability.

Why this matters

This is a caution for people with ALS or other motor neuron disease considering Mototab. The review does not provide evidence that Mototab benefits patients and does not support its use.

Limitations and context

This is an independent expert review from ALS Untangled, not a clinical trial or treatment guideline. The source does not provide clinical study results establishing Mototab’s effectiveness or safety.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?